佩蒂动物营养科技股份有限公司 投资者关系活动记录表 编号：IR2023-009 特定对象调研 分析师会议 投资者关系活动 媒体采访  业绩说明会 类别 新闻发布会 路演活动 现场参观 其他 Bright Valley Capital Limited：兰飞 Harding Loevner (Asia) Limited：沈文婷 Jefferies Financial Group Inc：廖诗画 Point72 Hong Kong Limited：王依菲 安信证券股份有限公司：冯永坤、夏心怡、金晓溪、周雅迪 保银资产管理有限公司：周冠群 北京金百镕投资管理有限公司：刘晓爽、刘新 参与单位名称及 北京京港伟业投资有限公司：杨雅涵 人员姓名（无排 北京凯读投资管理有限公司：辛植钧 名先后），由进 北京市星石投资管理有限公司：陈浩然 门财经 IRM 管 北京源峰私募基金管理合伙企业(有限合伙)：欧阳婧 理系统里导出， 北京中承东方资产管理有限公司：魏志鹏 本公司无法保证 毕盛(上海)投资管理有限公司：刘宏 参与人员真实身 博道基金管理有限公司：陈磊 份与名单的一致 财通证券股份有限公司：王宇璇、毕晓静 ...

Financial Performance - The company's operating revenue for Q3 2023 was ¥423,838,007.43, a decrease of 16.66% compared to the same period last year, and a year-to-date revenue of ¥916,492,284.39, down 32.34% year-on-year[5]. - Net profit attributable to shareholders for Q3 2023 was ¥13,537,705.47, a decline of 79.93%, with a year-to-date net profit of -¥29,159,639.55, down 118.47% year-on-year[5]. - The basic earnings per share for Q3 2023 was ¥0.05, representing an 81.48% decrease, while the diluted earnings per share was also ¥0.05, down 81.48%[5]. - Total operating revenue for Q3 2023 was ¥916,492,284.39, a decrease of 32.3% compared to ¥1,354,612,253.13 in the same period last year[24]. - The net profit for Q3 2023 was -30,131,102.16 CNY, compared to a net profit of 160,196,215.57 CNY in the same period last year, indicating a significant decline[25]. - The total operating expenses for Q3 2023 were 836,756,857.68 CNY, compared to 1,019,374,628.89 CNY in Q3 2022, reflecting a decrease of approximately 17.9%[25]. Assets and Liabilities - Total assets at the end of Q3 2023 were ¥2,914,903,364.53, an increase of 0.91% from the end of the previous year[5]. - Accounts receivable increased by 80.32% to ¥323,980,713.25, primarily due to an increase in overdue receivables[9]. - Total liabilities rose to ¥1,036,516,807.97, an increase of 7.1% compared to ¥967,189,497.90[22]. - Non-current assets totaled ¥1,295,729,649.57, an increase of 6.4% from ¥1,217,297,593.09[22]. - The company's cash and cash equivalents decreased to ¥665,694,648.49 from ¥832,606,271.14, representing a decline of 20.0%[22]. Cash Flow - The company's cash flow from operating activities showed a net outflow of -¥58,510,437.07, an improvement of 36.50% compared to the previous period[10]. - The net cash flow from financing activities was -¥49,595,262.72, a 55.26% improvement compared to the previous period, mainly due to reduced repayments of bank loans[10]. - The net cash flow from operating activities was -58,510,437.07 CNY, an improvement from -92,146,216.00 CNY in the previous year[26]. - The cash flow from financing activities was -49,595,262.72 CNY, an improvement from -110,857,583.54 CNY in the previous year[27]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 17,096[13]. - The largest shareholder, Chen Zhenbiao, holds 31.43% of shares, totaling 79,650,000 shares[13]. - The company has repurchased 5,282,135 shares, ranking among the top 10 shareholders[14]. - The top 10 shareholders include significant stakes from family members, indicating a concentrated ownership structure[14]. - The company has not disclosed any other significant shareholder relationships or agreements beyond those mentioned[14]. Stock and Equity Management - The company granted 455,000 restricted stocks at a price of 8.83 RMB per share on July 26, 2023[15]. - 832,000 shares from the first vesting period of the restricted stock plan were registered, accounting for 0.33% of the total share capital[17]. - 600,800 shares from the employee stock ownership plan were unlocked, representing 40% of the total stock in the plan and 0.24% of the company's total share capital[19]. - The stock repurchase and employee stock plan activities reflect the company's commitment to shareholder value[15][19]. - The company is actively managing its equity structure through stock grants and repurchases to align with performance goals[15][17]. Expenses and Investments - Research and development expenses for Q3 2023 were ¥21,531,924.54, slightly up from ¥20,352,352.73 year-over-year[24]. - Long-term equity investments rose by 284.42% to ¥53,531,929.70, due to increased external investments during the period[9]. - The company reported a financial income of ¥2,142,200.00, a significant improvement from a loss of ¥1,099,700.00 in the previous year[24].

证券代码：300673 证券简称：佩蒂股份 公告编号：2023-065 债券代码：123133 债券简称：佩蒂转债 佩蒂动物营养科技股份有限公司 关于回购公司股份的进展公告（截至 2023 年 10 月 23 日） 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导 性陈述或者重大遗漏。 2023年4月30日，佩蒂动物营养科技股份有限公司（以下简称公司）召开第三届 董事会第二十二次会议，审议通过了《关于以集中竞价方式回购公司股份方案的议案》， 同意公司通过竞价交易方式以不超过22.00元/股的价格回购公司已发行的人民币普通 股（A股）部分股票，拟全部用于公司发行的可转换公司债券的转股。公司本次回购 股份可使用的资金总额不低于人民币5,000万元且不超过7,000万元，回购资金来源于 公司自有资金，回购实施期限为自董事会审议通过本回购方案之日起不超过六个月。 回购方案的具体内容见公司分别于2023年5月4日、2023年5月6日在巨潮资讯网 （http://www.cninfo.com.cn/）披露的《关于以集中竞价方式回购公司股份方案的公告》 和《回购股份报告书》。 根据《深圳证券交易所上 ...

证券代码：300673 证券简称：佩蒂股份 公告编号：2023-063 债券代码：123133 债券简称：佩蒂转债 6、自开始转股始至2023年第三季度末止，共有1,708张佩蒂转债完成转股，票面 金额合计170,800.00元，合计转成本公司股票9,573股； 佩蒂动物营养科技股份有限公司 2023 年第三季度可转换公司债券转股情况公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导 性陈述或者重大遗漏。 特别提示： 1、债券代码：123133； 2、债券简称：佩蒂转债； 3、转股期起止日期：自2022年6月28日起至2027年12月21日止； 4、当前有效转股价格：人民币17.83元/股； 5、2023年第三季度，共有0张佩蒂转债（票面金额合计0元）完成转股，合计转 换成本公司股票0股； 7、截至2023年第三季度末，佩蒂转债尚存续7,198,292张，票面总金额人民币 719,829,200.00元。 一、可转换公司债券发行上市情况 经深圳证券交易所审核同意，中国证监会《关于同意佩蒂动物营养科技股份有限 公司向不特定对象发行可转换公司债券注册的批复》（证监许可〔2021〕359 ...

佩蒂动物营养科技股份有限公司 投资者关系活动记录表 | --- | --- | --- | |----------------|-------------------|-----------------| | | | 编号:IR2023-008 | | | 特定对象调研 | 分析师会议 | | 投资者关系活动 | 媒体采访 | 业绩说明会 | | 类别 | 新闻发布会 | 路演活动 | | | 现场参观 | 其他 | | | 中金公司:张宇茜 | | | | 安信证券:夏心怡 | | | | 湘财基金:朱依凡 | | | 参与单位名称及 | 浙商基金:韩佳伟 | | | 人员姓名(根据 | 太平基金:徐琳 | | | 参会单位拼音排 | 物产中大:林彬彬 | | | 序) | 云阳宜品:赵润峰 | | | | 宁涌富基金:祝海杰 | | | | 东吴自营:滕越 | | 双安资产:黄河 时间 2023 年 09 月 20 日(星期三) 地点及活动方式 浙江省杭州市萧山区宁围街道诺德财富中心 2001 董事会秘书、财务总监:唐照波; 上市公司接待人 品牌副总裁:李胤; 员姓名 会议记录:杨钰妍 一、董事会秘书唐照 ...

证券代码：300673 证券简称：佩蒂股份 公告编号：2023-062 债券代码：123033 债券简称：佩蒂转债 佩蒂动物营养科技股份有限公司 1. 本次归属的股票的过户日期为2023年9月13日； 2. 本次归属的股票数量为828,000股，占公司当前总股本的比例为0.33%； 3. 本次归属的股票授予价格：8.83元/股； 4. 本次归属的激励对象人数：228人； 5. 归属的股票来源：公司自二级市场回购的A股普通股股票。 2023年8月14日，佩蒂动物营养科技股份有限公司（以下简称公司）召开第三届 董事会第二十五次会议、第三届监事会第二十次会议，分别审议通过了《关于2022年 限制性股票激励计划首次授予第一个归属期符合归属条件的议案》，董事会认为公司 2022年限制性股票激励计划（以下简称本激励计划）首次授予第二类限制性股票的第 一个归属期已达成归属条件，同意根据公司2022年第四次临时股东大会的相关授权为 230名符合归属条件的首次授予激励对象办理832,000股第二类限制性股票的归属事 宜。独立董事发表了明确同意的独立意见，公司聘请的律师事务所和独立财务顾问分 别出具了法律意见书和独立财务顾问报告 ...

本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导 性陈述或者重大遗漏。 佩蒂动物营养科技股份有限公司（以下简称公司）2022年员工持股计划（以下简 称本持股计划）的第一个锁定期于2023年9月7日届满，根据《中华人民共和国公司法》 《中华人民共和国证券法》《关于上市公司实施员工持股计划试点的指导意见》及《深 圳证券交易所上市公司自律监管指引第2号——创业板上市公司规范运作》等有关法 律、行政法规、规章、规范性文件和《公司章程》的规定，现将本持股计划的第一个 锁定期届满及解锁情况公告如下： 一、本持股计划基本情况概述 （一）本持股计划的批准情况 2022年年7月11日，公司召开第三届董事会第十六次会议，审议通过了《关于<佩 蒂动物营养科技股份有限公司2022年员工持股计划（草案）>及其摘要的议案》《关于 <佩蒂动物营养科技股份有限公司2022年员工持股计划管理办法>的议案》《关于提请 股东大会授权董事会办理公司2022年员工持股计划有关事项的议案》等议案，同意公 司实施本持股计划，并提请股东大会审议批准。上述议案的具体内容见公司于2022年 7月12日在巨潮资讯网披露的《佩蒂动物营养科技 ...

证券代码：300673 证券简称：佩蒂股份 公告编号：2023-060 债券代码：123133 债券简称：佩蒂转债 佩蒂动物营养科技股份有限公司 关于回购公司股份的进展公告（截至 2023 年 8 月末） 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导 性陈述或者重大遗漏。 2023年4月30日，佩蒂动物营养科技股份有限公司（以下简称公司）召开第三届 董事会第二十二次会议，审议通过了《关于以集中竞价方式回购公司股份方案的议案》， 同意公司通过竞价交易方式以不超过22.00元/股的价格回购公司已发行的人民币普通 股（A股）部分股票，拟全部用于公司发行的可转换公司债券的转股。公司本次回购 股份可使用的资金总额不低于人民币5,000万元且不超过7,000万元，回购资金来源于 公司自有资金，回购实施期限为自董事会审议通过本回购方案之日起不超过六个月。 回购方案的具体内容见公司分别于2023年5月4日、2023年5月6日在巨潮资讯网 （http://www.cninfo.com.cn/）披露的《关于以集中竞价方式回购公司股份方案的公告》 和《回购股份报告书》。 根据《深圳证券交易所上市公司自律 ...

佩蒂动物营养科技股份有限公司 投资者关系活动记录表 | --- | --- | |----------------|-------------------------------------------| | | 编号:IR2023-007 | | | 特定对象调研分析师会议 | | 投资者关系活动 | 媒体采访 业绩说明会 | | 类别 | 新闻发布会路演活动 | | | 现场参观其他 | | | PHOENIXTREE CAPITAL:黄昱菡 | | | 安信证券股份有限公司:王朔、夏心怡、周雅迪 | | | 百嘉基金管理有限公司:杨钰其 | | | 北京金百镕投资管理有限公司:刘新、刘晓爽 | | | 北京源乐晟资产管理有限公司:卢奕璇 | | | 财通证券股份有限公司:王宇璇 | | | 上海)投资管理中心(有限合伙):白召然 | | | 大家资产管理有限责任公司:胡筱 | | | 东北证券股份有限公司:胡嘉祥 | | | 东方财富证券股份有限公司:朱张元 | | 参与单位名称及 | 东方证券股份有限公司:肖嘉颖 | | 人员姓名(根据 | 东海证券股份有限公司:陈涛 | | 参会单位拼音排 | 东吴 ...

Financial Performance - The company's revenue for the reporting period was ¥492,654,276.96, a decrease of 41.77% compared to the same period last year[25]. - The net profit attributable to shareholders was -¥42,697,345.02, representing a decline of 147.21% year-over-year[25]. - The basic and diluted earnings per share were both -¥0.17, down 147.22% from the previous year[25]. - Total assets at the end of the reporting period were ¥2,854,904,940.40, a decrease of 1.17% from the end of the previous year[25]. - The weighted average return on equity was -2.25%, a decrease of 9.17% compared to the previous year[25]. - The company's domestic market revenue reached RMB 125.83 million, showing a year-on-year increase of 63%[68]. - Total revenue decreased by 41.77% to RMB 492.65 million, mainly due to customer inventory adjustments and reduced orders[75]. - The gross profit margin for the "plant-based chew" product decreased by 12.12% year-on-year, reflecting a significant drop in revenue and cost[78]. - The company maintained a stable cost structure, with the main business cost decreasing by 32.92% to RMB 416.56 million due to reduced orders[76]. - The cash and cash equivalents decreased by 42.33% to RMB 145.31 million, indicating a tighter liquidity position[76]. Capital and Investment - The registered capital of the company has been changed to RMB 253.42 million as of June 8, 2023[24]. - The total investment amount for the reporting period was ¥66,598,276.50, a decrease of 83.76% compared to ¥410,111,500.00 in the same period last year[84]. - The company reported a total of ¥122,389.6 million in raised funds, with ¥1,659.83 million invested during the reporting period and a cumulative investment of ¥79,658.48 million[89]. - The company has a commitment to invest ¥13,803.62 million in a new high-quality pet food project in New Zealand, with a progress rate of 97.43%[92]. - The company has a commitment to invest ¥13,850 million in a pet food project in Cambodia, with a progress rate of 94.30%[92]. - The company has a new project for producing 5,000 tons of new pet food, with an investment of ¥26,535.98 million and a progress rate of 7.34%[92]. - The company has a new project for a pet comprehensive service center with an adjusted investment of ¥7,250 million, currently at 19.07% completion[92]. - The company has decided to terminate the pet service center project and redirect resources to online channels, enhancing efficiency in fund utilization[94]. - The company has approved the use of up to 250 million RMB of idle fundraising to temporarily supplement working capital for business-related operations[95]. Market Strategy and Operations - The company remains focused on the pet food industry, maintaining its core business and product offerings consistent with the previous year[34]. - The main products include animal skin chews and plant-based chews, which are positioned for growth in the domestic market due to increasing pet health awareness[35]. - The company has established large-scale production bases in Wenzhou, Taizhou, Vietnam, Cambodia, and New Zealand to provide various types of pet food for major global markets[38]. - The company has implemented a "big single product" strategy in the domestic market, focusing on creating leading products in niche markets to drive sales growth[49]. - The company has adopted an online and offline omnichannel strategy, establishing flagship stores on major e-commerce platforms and collaborating with regional distributors for offline sales[50]. - The company is exploring brand-building models that align with its strengths and the characteristics of the Chinese market, laying a solid foundation for future growth[68]. - The company is focusing on the development of its own brand and market expansion strategies[131]. Research and Development - The company has formed a research and development model focusing on independent R&D, with a dedicated team and platforms like the High-tech Enterprise R&D Center and Pet Health Nutrition Product Research Institute[43]. - The company has developed a robust R&D system, with multiple patents and a focus on innovative technologies to meet evolving consumer demands[61]. - The company is actively seeking to enhance its product R&D and innovation to mitigate the impact of rising labor costs by increasing product value and automation levels[113]. Risk Management - The company has detailed potential risks and countermeasures in the report, which investors should pay special attention to[5]. - The company faces risks related to high customer concentration, with overseas markets being the main source of revenue and profit[108]. - The company is exposed to raw material price fluctuation risks, particularly with significant increases in chicken and raw hide prices during the reporting period[109]. - The company is exposed to risks from international trade policies, particularly due to tariffs affecting exports to the U.S., which have been as high as 25% since 2018[116]. - The company is at risk from currency fluctuations, particularly as its export business is primarily dollar-denominated, which could lead to uncertain profitability[117]. - The company is committed to improving its overseas operational management and addressing potential risks from changes in foreign investment policies and local conditions[111]. Environmental and Social Responsibility - The company’s Wenzhou factory is recognized as a national-level green factory, with other subsidiaries striving to achieve similar standards[137]. - The company strictly adheres to local environmental regulations at its overseas factories, aiming to reduce carbon emissions and promote green development[138]. - The company reported a total emission of 0.11 tons of sulfur dioxide and 1.422 tons of nitrogen oxides, both compliant with the national air pollutant discharge standards[141]. - The company conducts regular environmental monitoring in accordance with national and local standards, ensuring compliance with disclosure regulations[146]. - The company emphasizes a commitment to social responsibility and actively engages in charitable activities[151]. Shareholder Information - The company reported a total share capital of 253,420,773 shares, with 64.61% being unrestricted shares[182]. - The company completed its first share repurchase on March 23, 2023, acquiring 4,602,535 shares, representing 1.8162% of the total share capital, at an average price of 16.29 RMB per share[184]. - The second share repurchase plan was approved on April 30, 2023, with a budget of 50 million to 70 million RMB, targeting a maximum price of 22.00 RMB per share[185]. - The total number of common shareholders at the end of the reporting period is 17,344[190]. - Chen Zhenbiao holds 31.43% of the shares, totaling 79,650,000 shares, with 59,737,500 shares under lock-up[190]. - The company has not experienced any changes in its board of directors, supervisors, or senior management during the reporting period[127].